APA (7th ed.) Citation

Caers, J., Hose, D., Kuipers, I., Bos, T. J., Van Valckenborgh, E., Menu, E., . . . Vanderkerken, K. (2010). Thymosin β4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma. Haematologica, the hematology journal, 95(1), . https://doi.org/10.3324/haematol.2009.006411

Chicago Style (17th ed.) Citation

Caers, Jo, et al. "Thymosin β4 Has Tumor Suppressive Effects and Its Decreased Expression Results in Poor Prognosis and Decreased Survival in Multiple Myeloma." Haematologica, the Hematology Journal 95, no. 1 (2010). https://doi.org/10.3324/haematol.2009.006411.

MLA (9th ed.) Citation

Caers, Jo, et al. "Thymosin β4 Has Tumor Suppressive Effects and Its Decreased Expression Results in Poor Prognosis and Decreased Survival in Multiple Myeloma." Haematologica, the Hematology Journal, vol. 95, no. 1, 2010, https://doi.org/10.3324/haematol.2009.006411.